Mycodern Stock

Mycodern Revenue

The The revenue of Mycodern (MCD.WA) as of Aug 16, 2026 is 2.12 M PLN. In the previous year, The revenue was 862,100.00 PLN — a change of 146.48% (higher).

Revenue

2.12 MPLN

YoY

146.48%

Last updated:

In 2026, Mycodern's sales reached 2.12 M PLN, a 146.48% difference from the 862,100.00 PLN sales recorded in the previous year.

Over the last 4 years Mycodern grew revenue by 4.5% annually, reaching 2.12 M PLN.

The Mycodern Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

REVENUE (M PLN)
GROSS MARGIN (%)
Date
REVENUE (M PLN)
GROSS MARGIN (%)
Jan 1, 2020
1.78 base
62.65 base
Jan 1, 2021
10.18 base
9.20 base
Jan 1, 2022
0.71 base
33.45 base
Jan 1, 2023
0.86 base
72.28 base
Jan 1, 2024
2.12 base
11.52 base
YEARREVENUE (M PLN)GROSS MARGIN (%)
2024 2.1211.52
2023 0.8672.28
2022 0.7133.45
2021 10.189.20
2020 1.7862.65
Access this data via the Eulerpool API
Get Free API Key

Mycodern Revenue

Mycodern Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
1.78 M PLN
-256,300.00 PLN
-283,200.00 PLN
Jan 1, 2021
10.18 M PLN
-5.00 M PLN
-4.98 M PLN
Jan 1, 2022
712,900.00 PLN
-371,000.00 PLN
-809,400.00 PLN
Jan 1, 2023
862,100.00 PLN
5.45 M PLN
-8,400.00 PLN
Jan 1, 2024
2.12 M PLN
73,100.00 PLN
-27.40 M PLN

Mycodern Margins

Mycodern stock margins

The Mycodern margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Mycodern. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Mycodern.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
62.65 %
-14.40 %
-15.91 %
Jan 1, 2021
9.20 %
-49.13 %
-48.94 %
Jan 1, 2022
33.45 %
-52.04 %
-113.54 %
Jan 1, 2023
72.28 %
632.32 %
-0.97 %
Jan 1, 2024
11.52 %
3.44 %
-1,289.31 %

Mycodern Stock analysis

What does Mycodern do? Mycodern is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Mycodern's Sales Figures

The sales figures of Mycodern originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Mycodern’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Mycodern's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Mycodern’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Mycodern stock

The revenue of Mycodern is 2.12 M PLN in 2026.

The revenue of Mycodern changed from 862,100.00 PLN to 2.12 M PLN, representing a 146.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The revenue Mycodern since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's Mycodern historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Mycodern

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Mycodern